Addex Therapeutics
ADXN
3 hedge funds and large institutions have $3.57M invested in Addex Therapeutics in 2020 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.
1,471% more capital invested
Capital invested by funds: $227K → $3.57M (+$3.34M)
50% more funds holding
Funds holding: 2 → 3 (+1)
0.04% more ownership
Funds ownership: 0% → 0.04% (+0.04%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CC
Caxton Corporation
Princeton,
New Jersey
|
+$3.08M |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$496 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$12.9K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CC
1
Caxton Corporation
Princeton,
New Jersey
| $3.56M | +$3.08M | +12,427 | +1,428% |
|
|
2
UBS Group
Zurich,
Switzerland
| $1K | -$12.9K | -52 | -91% |
|
|
TRCT
3
Tower Research Capital (TRC)
New York
| $1K | +$496 | +2 | New |
|
ADXN Hedge Fund Activity: Q4 2020 in Review
3 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Addex Therapeutics (ADXN) for Q4 2020, worth a combined $3.57M — up 1,471% from $227K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new ADXN positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Caxton Corporation, adding an estimated $3.08M. The largest seller was UBS Group, cutting an estimated $12.9K.
- 3 institutional investors held Addex Therapeutics (ADXN) as of Q4 2020, up from 2 in Q3 2020.
- Funds reported $3.57M of Addex Therapeutics stock for Q4 2020, up 1,471% quarter-over-quarter.
- 1 fund opened new Addex Therapeutics positions in Q4 2020 and 0 closed out, a net change of +1 holder.
- The largest Addex Therapeutics buyer in Q4 2020 was Caxton Corporation, an estimated $3.08M added.
- The largest Addex Therapeutics seller in Q4 2020 was UBS Group, an estimated $12.9K sold.
Based on aggregated 13F filings for Q4 2020.